ZVSA 8-K 2026-07-16

ZyVersa Therapeutics, Inc. (ZVSA) 8-K dated 2026-07-16 — accession 0001493152-26-033565.

ZyVersa Therapeutics, Inc. (ZVSA) is a biotechnology company listed on NASDAQ.

ZyVersa Therapeutics, Inc. filed a 8-K on 2026-07-16. Accession 0001493152-26-033565.

This 8-K covers: Other events (Item 8.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for ZVSA is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The ZVSA SEC hub lists recent forms. The stock page is the research view.